Keyword
Quick search:
Content Search
Result Content Outlet Published Research
Result Content Outlet Published Research
1 A would-be epic — in 60 seconds: Acadia and Strikeforce go cinematic for Parkinson's treatment Medical Marketing and Media 24 days ago
2 Acadia's narrows full-year guidance for Nuplazid sales, but shares rise after-hours Seeking Alpha 25 days ago
3 The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia marketscreener.com 3 days ago
4 A new drug reduces risk of psychosis relapse in patients with dementia Massive Science 17 days ago
5 NUPLAZID® (pimavanserin) Efficacy Data from Open-Label Extension (OLE) Study Published in Parkinsonism and Related Disorders Business Wire 6 months ago
6 Diabetes & Psych Disorders; FDA Pushes Schizophrenia Film Review Date; #Shadowwork MedPage Today 1 day ago
7 Acadia's Nuplazid Receives Regulatory Rejection for Dementia-Related Psychosis BioSpace 8 months ago
8 #AANAM – Nuplazid Not Linked to Side Effects Common to Antipsychotics Alzheimer's News Today 7 months ago
9 Acadia's surprise Nuplazid snag—and subsequent cold shoulder at FDA—beg more questions than answers FiercePharma 9 months ago
10 Nuplazid increases risk for death in older adults with Parkinson's disease Healio 3 months ago
11 Parkinson's Drug Tied to Increased Hospitalizations, Death MedPage Today 4 months ago
12 Three Pharma Companies Seek to Address FDA Rejections BioSpace 16 days ago
13 Parkinson's drug may ease dementia-linked psychosis UPI.com 4 months ago
14 FDA Approves Nuplazid for Capsule Sprinkling Parkinson's News Today 12 months ago
15 Acadia Pharmaceuticals to Present Data on Pimavanserin in Patients with Parkinson's Disease Dementia with Psychosis from the HARMONY trial at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference Business Wire 1 month ago
16 Many Parkinson's Patients Who Start Antipsychotics Discontinue Therapy Parkinson's News Today 5 months ago
17 Long-term Nuplazid Safe, Well-tolerated by Parkinson's Psychosis... Parkinson's News Today 1 year ago
18 Acadia Submits Supplemental New Drug Application for Nuplazid Parkinson's News Today 1 year ago
19 ACADIA Pharmaceuticals Announces U.S. FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis Business Wire 1 year ago
20 Nuplazid Shows Sustained Easing of Parkinson's Psychosis, Trial Reports Parkinson's News Today 1 year ago
21 Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer's Association International Conference 2021 (AAIC) Business Wire 5 months ago
22 FDA to Review Nuplazid as Treatment for Dementia-related Psychosis Parkinson's News Today 1 year ago
23 HealthWell Opens Fund to Help Parkinson's Patients With Psychosis Parkinson's News Today 2 months ago
24 Add-On Nuplazid Gets a Win in Early Schizophrenia Trial MedPage Today 1 year ago
25 Nuplazid (Pimavanserin) for Parkinson's Disease Parkinson's News Today 5 years ago
26 FDA to Consider Nuplazid for Dementia-related Psychosis in Alzheimer's, Other Ills Alzheimer's News Today 1 year ago
27 ACADIA Pharmaceuticals Submits Supplemental New Drug Application to US FDA for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis BioSpace 1 year ago
28 Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire 9 months ago
29 FDA worried drug was risky; now reports of deaths spark concern CNN 4 years ago
30 New Parkinson's psychosis drug target of DOJ investigation CNN 3 years ago
31 Parkinson's and Other Patients Show Nuplazid 'Significantly' Delays Dementia-Related Psychosis in Phase 3 Trial Parkinson's News Today 2 years ago
32 Acadia's Nuplazid Fails to Prove Effectiveness in Schizophrenia Trial BioSpace 2 years ago
33 Once-a-day Capsule for Nuplazid and Lower Dose Option Approved for... Parkinson's News Today 3 years ago
34 Parkinson's hallucinations: Causes, treatment, and more Medical News Today 27 days ago
35 Nuplazid’s schizophrenia flop provides Advance warning Vantage 2 years ago
36 Acadia's Nuplazid Hits the Mark in Late-Stage Dementia-Related Psychosis Trial BioSpace 2 years ago
37 Safety watchdog questions FDA's approval of Parkinson's psychosis drug CNN 3 years ago
38 Acadia's Nuplazid Shows Mixed Results in Major Depression Study BioSpace 1 year ago
39 New drug for psychosis in Parkinson's raises hopes — and concerns STAT 6 years ago
40 FDA approves new formulation, dosage strength of Nuplazid for Parkinson's psychosis Healio 3 years ago
41 The rising cost of prescription drugs has many people skipping their medications ksltv.com 2 months ago
42 Acadia calls early halt to Nuplazid psychosis trial after promising interim results FiercePharma 2 years ago
43 Acadia's Nuplazid could hit blockbuster heights after strong psychosis data: analyst FiercePharma 2 years ago
44 Acadia's Nuplazid misses the mark in major depressive disorder trial PMLiVE 1 year ago
45 Parkinson's Psychosis Therapies Nuplazid and Clozaril Touted in Review Parkinson's News Today 4 years ago
46 Acadia Pharmaceuticals: Refunding A Former Champion Seeking Alpha 2 months ago
47 Nuplazid Eases Depression in Parkinson's Patients, Phase 2 Trial Shows Parkinson's News Today 2 years ago
48 Acadia debuts first Nuplazid branded ads, aiming to spark talk of Parkinson's psychosis FiercePharma 3 years ago
49 Nuplazid Review Endorses Treatment, But Pinpoints Areas for More Study Parkinson's News Today 4 years ago
50 FDA concludes examination of Parkinson's drug CNN 3 years ago
51 Acadia looks to 'blow up the paradigm' with Parkinson's psychosis drug Nuplazid FiercePharma 3 years ago
52 ACADIA Pharmaceuticals Announces Top-line Results from Phase 3 ENHANCE Trial of Pimavanserin as Adjunctive Treatment for Patients with Schizophrenia Business Wire 2 years ago
53 No new way for Nuplazid after depression failure Vantage 1 year ago
54 Experts: Nuplazid's Risks for Parkinson's Psychosis Don't Appear Too High Parkinson's News Today 3 years ago
55 Parkinson's Therapy Nuplazid (Pimavanserin) Reviewed as Treatment for Psychosis Parkinson's News Today 4 years ago
56 FDA Continuing to Monitor Nuplazid Use, Agency Says in Response to... Parkinson's News Today 4 years ago
57 #AAN2018 Nuplazid's Safety, Efficacy in Treating Parkinson's Psychosis Seen in Real-life Studies 4 years ago
58 ACADIA Pharmaceuticals Announces Top-line Results from the Phase 3 CLARITY Study Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder Business Wire 1 year ago
59 Acadia readies new round of Nuplazid DTC as federal marketing probe continues FiercePharma 2 years ago
60 FDA's toughness toward AbbVie, FibroGen and Acadia raise worries of more stringent drug reviews: analyst FiercePharma 9 months ago
61 Study Weighs Nuplazid, Seroquel Mortality Risks in Parkinson's Psychosis Parkinson's News Today 3 years ago
62 Nuplazid Delays Psychosis Relapses in Alzheimer's, Other Dementia-related Diseases, Phase 3 Study Shows Alzheimer's News Today 2 years ago
63 FDA Approves ACADIA Pharmaceuticals' NUPLAZID™ (pimavanserin) The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson's Disease Psychosis 6 years ago
64 Forbes Ranks Maker of Nuplazid 11th-Most Innovative Growth Company Parkinson's News Today 4 years ago
65 FDA Advisory Committee Concludes Nuplazid Beneficial for Parkinson's Disease Psychosis Treatment Parkinson's News Today 6 years ago
66 FDA re-examines safety of controversial new drug CNN 4 years ago
67 Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc. Business Wire 11 months ago
68 Is The FDA Going To Do Anything About Acadia Pharmaceuticals' Nuplazid? Seeking Alpha 3 years ago
69 Nuplazid drug can curb dementia’s delusions, researchers find syracuse.com 2 years ago
70 ACADIA Pharmaceuticals Files New Drug Application for NUPLAZID In... Parkinson's News Today 6 years ago
71 Acadia's Big Date Seeking Alpha 1 year ago
72 'Erratic' FDA and inconsistent drug decisions put doctors off new meds: survey FiercePharma 4 months ago
73 Is Acadia Pharmaceuticals a Good Biotech Stock to Buy Now? Motley Fool 2 years ago
74 New Phase 3 Trial to Test Nuplazid for Parkinson's Psychosis in... Parkinson's News Today 4 years ago
75 5 FDA approval decisions to watch in the second quarter BioPharma Dive 8 months ago
76 ACADIA Pharmaceuticals Reports Second Quarter 2020 Financial Results Business Wire 1 year ago
77 FDA approves first drug to treat hallucinations and delusions associated with Parkinson's disease | FDA FDA.gov 6 years ago
78 New ADHD Drug OK'd; Pimavanserin Rejected for Dementia Psychosis MedPage Today 8 months ago
79 Acadia: Surprise, Surprise Seeking Alpha 8 months ago
80 FDA Action Alert: Merck, Aveo and Acadia BioSpace 8 months ago
81 No change in FDA's position on Parkinson's drug Nuplazid The San Diego Union-Tribune 4 years ago
82 Don't be rash when approving medications | Silver Chips Silver Chips Online 4 years ago
83 FDA Repays Industry by Rushing Risky Drugs to Market ProPublica 3 years ago
84 Drug can curb dementia’s delusions, researchers find The Detroit News 2 years ago
85 Treating Parkinson's Psychosis with Oral Cannabidiol Focus of UK Phase 2 Study Parkinson's News Today 2 years ago
86 Can These Former Biotech Growth Stocks Regain Their Form? Motley Fool 2 months ago
87 U.S. approves first drug for psychosis linked to Parkinson's Reuters 6 years ago
88 Acadia Pharma drug fails to improve psychosis in schizophrenia patients STAT 2 years ago
89 Is Drug Good for Some Alzheimer’s Patients? The Wall Street Journal 7 months ago
90 Acadia Pharmaceutical's Nuplazid Pricing Is Good News for Shareholders TheStreet.com 6 years ago
91 Neurocrine, ACADIA: Fast Growing Health Care Stocks That Are Underperforming Forbes 1 month ago
92 ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual JPMorgan Healthcare Conference (Transcript) Seeking Alpha 11 months ago
93 Alzheimer’s and Covid-19 developers make hay on the stock markets Vantage 5 months ago
94 Best Stocks of the Decade: Acadia’s Drug Development Success TheStreet 2 years ago
95 Acadia Halts Work on Depression Drug After Late-Stage Trial Failure Xconomy 1 year ago
96 U.S. FDA accepts Acadia's application for dementia drug Reuters 1 year ago
97 Drug can curb dementia´s delusions, researchers find Daily Mail 2 years ago
98 FDA OKs Pimavanserin for Hallucinations in Parkinson's MedPage Today 5 years ago
99 Acadia adds pain meds to the pipeline with $52.5M CerSci buyout FierceBiotech 1 year ago
100 After US approval Aveo faces a monumental task Vantage 9 months ago